China · Delayed Price · Currency is CNY APT Medical Statistics
Total Valuation
APT Medical has a market cap or net worth of CNY 36.14 billion. The enterprise value is 34.69 billion.
| Market Cap | 36.14B |
| Enterprise Value | 34.69B |
Important Dates
The last earnings date was Wednesday, March 25, 2026.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | Jun 19, 2025 |
Share Statistics
APT Medical has 140.63 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 140.63M |
| Shares Outstanding | 140.63M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 20.04% |
| Owned by Institutions (%) | 32.48% |
| Float | 75.03M |
Valuation Ratios
The trailing PE ratio is 44.31 and the forward PE ratio is 35.02.
| PE Ratio | 44.31 |
| Forward PE | 35.02 |
| PS Ratio | 13.99 |
| PB Ratio | 11.55 |
| P/TBV Ratio | 13.64 |
| P/FCF Ratio | 52.98 |
| P/OCF Ratio | 37.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.77, with an EV/FCF ratio of 50.85.
| EV / Earnings | 42.27 |
| EV / Sales | 13.42 |
| EV / EBITDA | 34.77 |
| EV / EBIT | 39.06 |
| EV / FCF | 50.85 |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.62 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | 608.06 |
Financial Efficiency
Return on equity (ROE) is 28.42% and return on invested capital (ROIC) is 46.17%.
| Return on Equity (ROE) | 28.42% |
| Return on Assets (ROA) | 16.74% |
| Return on Invested Capital (ROIC) | 46.17% |
| Return on Capital Employed (ROCE) | 27.81% |
| Weighted Average Cost of Capital (WACC) | 2.85% |
| Revenue Per Employee | 828,713 |
| Profits Per Employee | 263,193 |
| Employee Count | 3,118 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 1.59 |
Taxes
In the past 12 months, APT Medical has paid 128.55 million in taxes.
| Income Tax | 128.55M |
| Effective Tax Rate | 13.73% |
Stock Price Statistics
The stock price has decreased by -13.63% in the last 52 weeks. The beta is -0.26, so APT Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.26 |
| 52-Week Price Change | -13.63% |
| 50-Day Moving Average | 238.68 |
| 200-Day Moving Average | 269.86 |
| Relative Strength Index (RSI) | 60.03 |
| Average Volume (20 Days) | 1,189,353 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APT Medical had revenue of CNY 2.58 billion and earned 820.64 million in profits. Earnings per share was 5.80.
| Revenue | 2.58B |
| Gross Profit | 1.88B |
| Operating Income | 888.01M |
| Pretax Income | 936.29M |
| Net Income | 820.64M |
| EBITDA | 988.48M |
| EBIT | 888.01M |
| Earnings Per Share (EPS) | 5.80 |
Balance Sheet
The company has 1.51 billion in cash and 19.40 million in debt, with a net cash position of 1.50 billion or 10.63 per share.
| Cash & Cash Equivalents | 1.51B |
| Total Debt | 19.40M |
| Net Cash | 1.50B |
| Net Cash Per Share | 10.63 |
| Equity (Book Value) | 3.13B |
| Book Value Per Share | 21.96 |
| Working Capital | 1.66B |
Cash Flow
In the last 12 months, operating cash flow was 967.76 million and capital expenditures -285.59 million, giving a free cash flow of 682.17 million.
| Operating Cash Flow | 967.76M |
| Capital Expenditures | -285.59M |
| Depreciation & Amortization | 100.47M |
| Net Borrowing | 7.61M |
| Free Cash Flow | 682.17M |
| FCF Per Share | 4.85 |
Margins
Gross margin is 72.62%, with operating and profit margins of 34.37% and 31.76%.
| Gross Margin | 72.62% |
| Operating Margin | 34.37% |
| Pretax Margin | 36.24% |
| Profit Margin | 31.76% |
| EBITDA Margin | 38.26% |
| EBIT Margin | 34.37% |
| FCF Margin | 26.40% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.39%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.39% |
| Dividend Growth (YoY) | 26.88% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 20.75% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 0.33% |
| Earnings Yield | 2.27% |
| FCF Yield | 1.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 19, 2025. It was a forward split with a ratio of 1.45.
| Last Split Date | Jun 19, 2025 |
| Split Type | Forward |
| Split Ratio | 1.45 |
Scores
APT Medical has an Altman Z-Score of 47.78 and a Piotroski F-Score of 7.
| Altman Z-Score | 47.78 |
| Piotroski F-Score | 7 |